Pro64His (rs4644) polymorphism within galectin-3 is a risk factor of differentiated thyroid carcinoma and affects the transcriptome of thyrocytes engineered via CRISPR/Cas9 system
published in: Thyroid
date of publication: 2020-12-14
main subject: differentiated thyroid carcinoma, CRISPR, Cas9
Cites articles
There is nothing here
Article - wd:Q104287948